Dr. Geoffrey I. Shapiro
Claim this profileDana-Farber Cancer Institute
Expert in Solid Tumors
Expert in Tumors
26 reported clinical trials
57 drugs studied
About Geoffrey I. Shapiro
Education:
- Earned both PhD (1987) and MD (1988) degrees from Cornell University.
Experience:
- Completed postgraduate training in internal medicine at Beth Israel Hospital, Boston, and served as chief medical resident.
- Undertook a fellowship in medical oncology at Dana-Farber Cancer Institute.
- Has been a part of the Dana-Farber faculty since 1994.
- Currently leads early phase clinical trials at the Center for Cancer Therapeutic Innovation, with a focus on cell cycle and DNA repair inhibitor therapeutics.
- Holds the position of Senior Vice President, Developmental Therapeutics at Dana-Farber Cancer Institute.
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
BRCA1 positive
2Tumors
Global LeaderStage IV
Stage III
BRCA1 positive
Affiliated Hospitals
Clinical Trials Geoffrey I. Shapiro is currently running
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting1 award Phase 1 & 25 criteria
Palbociclib + Gedatolisib
for Solid Cancers
This research study is studying a combination of drugs as a possible treatment for cancer that might have a specific change in the phosphatidylinositol-3 phosphate (PI3K) pathway.
Recruiting1 award Phase 1
More about Geoffrey I. Shapiro
Clinical Trial Related8 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Geoffrey I. Shapiro has experience with
- Olaparib
- Pembrolizumab
- Gemcitabine
- Palbociclib
- Fulvestrant
- Binimetinib
Breakdown of trials Geoffrey I. Shapiro has run
Solid Tumors
Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Geoffrey I. Shapiro specialize in?
Geoffrey I. Shapiro focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Geoffrey I. Shapiro currently recruiting for clinical trials?
Yes, Geoffrey I. Shapiro is currently recruiting for 10 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Geoffrey I. Shapiro has studied deeply?
Yes, Geoffrey I. Shapiro has studied treatments such as Olaparib, Pembrolizumab, Gemcitabine.
What is the best way to schedule an appointment with Geoffrey I. Shapiro?
Apply for one of the trials that Geoffrey I. Shapiro is conducting.
What is the office address of Geoffrey I. Shapiro?
The office of Geoffrey I. Shapiro is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.